Members of Harvard Medical School’s Class of 2015 tear open envelopes that reveal where they will spend the next three to seven years of their training in residency programs.
Researchers have found that measles vaccine coverage among the exposed populations is far below that necessary to keep the virus in check. The study is the first to positively link measles vaccination rates and the ongoing outbreak.
New research from Harvard and MIT shows that different cognitive skills peak at different times in lifespan.
Harvard Medical School’s light-filled Gordon Hall reflects how students once learned.
Harvard University announced 20 student-led teams on Monday as finalists in four Deans’ Challenges focused on cultural entrepreneurship, health and life sciences, the food system, and innovation in sports.
Harvard Stem Cell Institute researchers at McLean Hospital have taken what they describe as an important step toward using the implantation of stem cell-generated neurons as a treatment for Parkinson’s disease.
Researchers have identified a group of neurons in the brain. The role of this cell type, in a region of the brain important for “waking up the cortex,” had not been previously identified. It may suggest potential therapies for disorders like schizophrenia.
Harvard Medical School and Massachusetts General Hospital Professor Emery N. Brown, who also holds appointments at the Massachusetts Institute of Technology, was named to the National Academy of Engineering in early February.
Harvard psychiatrist Jacqueline Olds offers some tips for coping with the snow and the dark days of winter.
Escaped slave and abolitionist Lewis Hayden’s work goes on, through the students who receive the scholarship established in his name at Harvard Medical School.
Richard Anthony LaBrie, 76, of Watertown, who long held an affiliation with Harvard Medical School (HMS), died Dec. 31, 2014.
Harvard-affiliated researchers have provided a see-through zebrafish and enhanced imaging that offer the first direct glimpse of how blood stem cells take root in the body to generate blood.
Harvard researchers at Brigham and Women’s Hospital have uncovered a way to enhance and prolong the therapeutic effects of mesenchymal stem cells in a preclinical model of type 1 diabetes.
Imaging study finds the first evidence of neuroinflammation in brains of chronic pain patients, which could lead to new, targeted treatments.
Framingham Heart Study, PNAS Early Edition, Harvard Medical School Investigators working to unravel the impact of genetics versus environment on traits such as obesity may also need to consider a new factor: when individuals were born.
A team of researchers led by Harvard geneticist George Church at the Wyss Institute for Biologically Inspired Engineering and Harvard Medical School has made big strides toward a future in which the predominant chemical factories of the world are colonies of genetically engineered bacteria.
The Eleanor and Miles Shore 50th Anniversary Fellowship Program for Scholars in Medicine provides support for junior faculty amid life’s crunch time, when demanding research labs, children at home, and other duties all clamor for attention.
With Harvard’s Vivek Murthy confirmed as the next surgeon general, health experts shared their views on areas where his focus and influence are most needed.
As protests around the nation continued in the wake of decisions by grand juries in Missouri and New York not to indict police officers in the deaths of two unarmed black men, hundreds of Harvard community members expressed their own anger, frustration, and desire for changes in the criminal justice system with a range of campus activities.
Expanded medical care could greatly reduce Ebola fatalities, says Paul Farmer of Partners In Health.
Poet and memoirist Meghan O’Rourke is using her time as a Radcliffe Fellow to write “What’s Wrong With Me,” a chronicle of her struggles with autoimmune disease.
A study by Harvard researchers is the first to explore new parents’ attitudes toward genomic testing on newborns. The findings suggest that if such testing becomes available, there would be an interest among new parents, regardless of their demographic background.
Harvard researchers have uncovered an easily detectable, “premalignant” state in the blood that significantly increases the likelihood that an individual will go on to develop blood cancers such as leukemia, lymphoma, or myelodysplastic syndrome.
A new genetic test developed by Harvard Medical School physicians at the Dana-Farber/Brigham and Women’s Cancer Center checks cells of leukemia and other blood cancers for 95 genetic mutations, providing a quick genetic profile that physicians can use to make treatment decisions.
The recipient of a bilateral arm transplant and his surgeons appeared at a news conference on Tuesday to thank the donor’s family and to discuss the procedure.
Harvard Stem Cell Institute scientists at Brigham and Women’s Hospital have found the cellular origin of the tissue scarring caused by organ damage associated with diabetes, lung disease, high blood pressure, kidney disease, and other conditions.
Raphael Dolin of the Medical School discusses the evidence for hand washing, the timing of flu season, and who’s most vulnerable to serious complications.
The Bertarelli Program in Translational Neuroscience and Neuroengineering, a collaborative program between Harvard Medical School and the École Polytechnique Fédérale de Lausanne in Switzerland, has announced a new set of grants worth $3.6 million for five research projects.
New research illuminates the mixing with Neanderthals in early human prehistory, narrowing the window of time when they crossbred to between 50,000 and 60,000 years ago.
Harvard geneticist George Church discussed the future of genetic engineering, including possible technological applications allowing new treatment techniques. He saw the potential to improve human health, revolutionize pest management, and perhaps even bring back the mammoth and other extinct species.
Four scientists from across Harvard will receive nearly $8 million in grant funding through the National Institutes of Health’s High Risk-High Reward program to support research into a variety of biomedical questions, ranging from how the bacterial cell wall is constructed to how the blood-brain barrier works.
In a study reported in Nature Biotechnology, a team of Harvard scientists and engineers has developed a new surface coating for medical devices using materials already approved by the Food and Drug Administration (FDA). The researchers noted that the coating repelled blood from more than 20 medically relevant substrates (glass, plastic, and metal) and also suppressed biofilm formation.
Research led by Harvard investigators has found six new genes underlying coffee-drinking behavior.
Three nonprofits with strong Harvard ties have joined forces at the front lines of the Ebola epidemic in West Africa.
Six Harvard Medical School (HMS) researchers were among the recipients of the 2014 António Champalimaud Vision Award, the highest distinction in ...
New research from the lab of David Reich challenges the prevailing view among archaeologists that there were no major influxes of new peoples into Europe after the advent of agriculture.
Harvard researchers working at the Broad Institute of MIT and Harvard have uncovered nine rare genetic mutations that dramatically increase the risk of developing type 2 diabetes. The discovery of the mutations highlights the dizzying genetic diversity of a disease rapidly spreading around the world.
A new device inspired by the human spleen and developed by a team at Harvard’s Wyss Institute for Biologically Inspired Engineering may radically transform the way doctors treat sepsis.
The Harvard Program in Therapeutic Science has received $30 million in grant funding over the five years from three U.S. government agencies to launch its new research activities, Harvard Medical School announced on Sept. 11.
Harvard Humanitarian Initiative researchers polled residents of a war-torn part of the Democratic Republic of the Congo, finding that though many think the security situation has improved, trust in government is at a low ebb.
For 30 years, the Victims of Violence program at Harvard-affiliated Cambridge Health Alliance has been a force in trauma care.
Researchers at Harvard-affiliated McLean Hospital are reporting that xenon gas, used in humans for anesthesia and diagnostic imaging, has the potential to be a treatment for post-traumatic stress disorder (PTSD) and other memory-related disorders
The protective gear needed to get Sierra Leone’s health clinics reopened, coupled with public education about the Ebola epidemic, are the greatest areas of need, according to a Harvard Fulbright Fellow and physician from Sierra Leone.
Though the threat to the U.S. population from the Ebola outbreak in West Africa is low, the need in epidemic countries is great, says Michael VanRooyen, director of the Harvard Humanitarian Initiative.
To David Altshuler, the recent discovery of a genetic mutation that protects against type 2 diabetes offers hope in fighting more than just diabetes. It ...
A new technique for observing neural activity will allow scientists to stimulate neurons and observe their firing pattern in real time. Tracing those neural pathways can help researchers answer questions about how neural signals propagate, and could one day allow doctors to design individualized treatments for a host of disorders.
New research raises the prospect of more effective treatments for cachexia, a profound wasting of fat and muscle that occurs in about half of all cancer patients, increasing their risk of death. Harvard Professor Bruce Spiegelman demonstrated that symptoms of cachexia in mice improved when given an antibody that blocked the effects of a protein secreted by the tumor cells.
A new study found that two-child families present five times more risk of sibling obesity than single-child homes with an obese parent, which doubles the risk. Obesity risk is even stronger among same-gender siblings.
Several Harvard students and alumni will work in some of Brazil’s most underserved communities this summer, helping change lives through soccer.
Will Lautzenheiser, a former Boston University film professor who lost his arms and legs from an infection, has been cleared by the Institutional Review Board at the Harvard-affiliated Brigham and Women’s Hospital for a double arm transplant, a complex procedure requiring 12 to 16 hours of work by a team of surgeons.